Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stereotactic Radiosurgery Prognosis Assessment for Spinal Tumors Based on Radiomics

NCT05369689 is registered in ClinicalTrials.gov with Zhuang Hongqing as lead sponsor.

NCT NCT05369689
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05369689 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stereotactic Radiosurgery Prognosis Assessment for Spinal Tumors Based on Radiomics
Lead sponsor
Zhuang Hongqing
Phase
Observational
Overall status
Not yet recruiting
Start date
June 1, 2022
Completion date
June 1, 2027
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prognosis, radiomics, spinal tumor, stereotactic radiosurgery